The global Bronchopulmonary Dysplasia Treatment Market is expected to be worth US$ 346 million in 2022 and US$ 661.7 million by 2032, growing at a CAGR of 6.1% during the forecast period. The increasing cases of bronchopulmonary dysplasia, as well as the rise in premature births, can be attributed to the growth of t.
/PRNewswire/ Regenerative Medicine Market is projected to reach USD 40.6 billion by 2027 from USD 12.2 billion in 2022, at a CAGR of 27.2% according to a.
/PRNewswire/ Verified Market Research recently published a report, "Stem Cell Therapy Market" By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells,.
/PRNewswire/ According to Coherent Market Insights, the global stem cell therapy market is estimated to be valued at US$ 15,075.5 million in 2022 and is.